We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approves New Drug for Hodgkin Lymphoma

News   Apr 20, 2017 | Original story from National Cancer Institute

 
FDA Approves Pembrolizumab for Hodgkin Lymphoma

Anatomical illustration of lymphoma. Credit: Terese Winslow

 
 
 

RELATED ARTICLES

Pre-symptomatic Skin Test for Prion Disease May Replace Brain Biopsy

News

Preclinical detection of prions has proven difficult, but new research suggests skin samples hold early signs of prion disease that precede neurologic symptoms.

READ MORE

Sending Out the Wrong Signals

News

A signaling pathway to immune cells controlled by TGFβ could be involved in the progression of age-related macular degeneration

READ MORE

Powerful Microscope Reveals Motility Nanoscaffold

News

Using one of the most powerful microscopes in the world, scientists have identified a dense, dynamic and disorganized actin filament nanoscaffold that is induced in response to a molecular signal.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE